Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cytokine immunogene therapy.

R P Glick1, T Lichtor, E P Cohen

  • 1Departments of Neurosurgery, Anatomy and Cell Biology, Rush Medical College, Cook County Hospital, 1835 West Harrison, Chicago, Illinois 60612, USA.

Neurosurgical Focus
|July 5, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chronic GVHD and concurrent new-onset nephrotic syndrome in allogeneic transplant recipients. Incidence, pattern and therapeutic outcomes.

Bone marrow transplantation·2014
Same author

Mitigation of radiation injuries via suppression of the renin-angiotensin system: emphasis on radiation nephropathy.

Current drug targets·2010
Same author

Gene expression of neurotrophic factors in human brain tumors.

Molecular and cellular neurosciences·2009
Same author

[The physiopathology of dialysis-associated hypertension].

Nephrologie & therapeutique·2008
Same author

Salt, the kidneys, and arterial hypertension.

Acta clinica Belgica·2008
Same author

Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes.

Kidney international·2007
Same journal

Letter to the Editor. Enhancing comparability in idiopathic intracranial hypertension research through standardized outcome measures.

Neurosurgical focus·2026
Same journal

Introduction. Contemporary spinal arthroplasty.

Neurosurgical focus·2026
Same journal

Cervical disc arthroplasty as a safe and effective procedure for obese patients.

Neurosurgical focus·2026
Same journal

Comparing the operational metrics and functional outcomes of lumbar arthroplasty implants: a systematic review.

Neurosurgical focus·2026
Same journal

Long-term reoperation risk after cervical disc arthroplasty versus fusion: a level-matched meta-analysis of FDA investigational device exemption studies and international randomized trials.

Neurosurgical focus·2026
Same journal

Total disc replacement versus lumbar interbody fusion for degenerative disc disease: a meta-analysis of randomized controlled trials.

Neurosurgical focus·2026
See all related articles

New immunogene therapy using cytokine-secreting cells shows promise for treating brain tumors. This novel approach stimulates an antitumor immune response, significantly improving survival in preclinical models of malignant brain tumors.

Area of Science:

  • Oncology
  • Immunotherapy
  • Gene Therapy

Background:

  • Malignant brain tumors, both primary and metastatic, have a poor prognosis.
  • Current therapies for brain tumors are insufficient, necessitating novel treatment strategies.
  • Tumors often evade the host's immune system, preventing effective tumor elimination.

Purpose of the Study:

  • To develop and evaluate a novel immunogene therapy for primary and metastatic brain tumors.
  • To investigate the potential of cytokine-secreting cellular vaccines to elicit an antitumor immune response.
  • To assess the efficacy of this therapy in improving survival rates for malignant brain tumors.

Main Methods:

  • Genes encoding cytokines were transferred into a fibroblast cell line to create a cellular vaccine.

Related Experiment Videos

  • The cellular vaccine was administered intratumorally in preclinical models of intracerebral tumors.
  • Immune response augmentation strategies were explored in conjunction with the vaccine.

    • Main Results:

    • Treatment with the allogeneic cytokine-secreting vaccine significantly increased survival in mice with intracerebral glioma, melanoma, and breast cancer.
    • The vaccine successfully stimulated a systemic antitumor immune response.
    • Evidence of immune stimulation included immunocytotoxicity, histopathological changes, and delayed immune memory.

    Conclusions:

    • Immunogene therapy represents a promising, targeted treatment approach for intracerebral malignant tumors.
    • The developed cellular vaccine effectively harnesses the immune system to combat brain tumors.
    • Further research into immunogene therapy could lead to improved long-term survival for brain tumor patients.